Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 13;8(2):e1273. doi: 10.1097/TXD.0000000000001273

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

FIGURE 4. — Competing risk cumulative incidences of GF and DWFG. A, Overall graft loss, GF, and DWFG. DWFG is more common over time than GF (P = 0.006). B, Incidence curves for each type of GF. Alloimmune causes are more common than all other causes (P < 0.001 comparing restricted mean survival). C, GF and DWFG for recipients <55 y old vs >55 y old. GF is higher in younger group (P < 0.001), and DWFG is higher in older recipients (P < 0.001). D, GF and DWFG in recipients stratified by diabetes as the cause of ESRD. DWFG is more common in diabetics (P < 0.001), whereas GF is similar in diabetics and nondiabetics (P = 0.071). E, GF due to alloimmune and nonalloimmune causes for recipients <55 vs >55. Younger patients have higher rates of GF due to alloimmune causes (P < 0.001); GF due to nonalloimmune causes are similar. F, GF from alloimmune and nonalloimmune causes stratified by diabetes as the cause of ESRD. Diabetics have higher rates of nonalloimmune GF (P = 0.002) but similar rates of alloimmune GF. BK, polyoma virus; DWFG, death with a functioning graft; ESRD, end-stage renal disease; GF, graft failure.